These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33251048)

  • 1. Improved Cancer Targeting by Multimerizing Aptamers on Nanoscaffolds.
    Omer M; Andersen VL; Nielsen JS; Wengel J; Kjems J
    Mol Ther Nucleic Acids; 2020 Dec; 22():994-1003. PubMed ID: 33251048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.
    Lupold SE
    Am J Clin Exp Urol; 2018; 6(2):78-86. PubMed ID: 29666835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
    Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA
    ACS Nano; 2019 Nov; 13(11):12301-12321. PubMed ID: 31664817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers and their applications in nanomedicine.
    Sun H; Zu Y
    Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
    Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R
    Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers as imaging agents.
    Gomes Sda R; Azéma L; Allard M; Toulmé JJ
    Expert Opin Med Diagn; 2010 Nov; 4(6):511-8. PubMed ID: 23496229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
    Vorhies JS; Nemunaitis JJ
    Biologics; 2007 Dec; 1(4):367-76. PubMed ID: 19707307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-iRNAs as Therapeutics for Cancer Treatment.
    Soldevilla MM; Meraviglia-Crivelli de Caso D; Menon AP; Pastor F
    Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30340426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-targeting aptamers act as intracellular delivery vehicles.
    Gopinath SC; Lakshmipriya T; Chen Y; Arshad MK; Kerishnan JP; Ruslinda AR; Al-Douri Y; Voon CH; Hashim U
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):6955-69. PubMed ID: 27350620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.
    Musumeci D; Montesarchio D
    Pharmacol Ther; 2012 Nov; 136(2):202-15. PubMed ID: 22850531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.
    Amero P; Lokesh GLR; Chaudhari RR; Cardenas-Zuniga R; Schubert T; Attia YM; Montalvo-Gonzalez E; Elsayed AM; Ivan C; Wang Z; Cristini V; Franciscis V; Zhang S; Volk DE; Mitra R; Rodriguez-Aguayo C; Sood AK; Lopez-Berestein G
    J Am Chem Soc; 2021 May; 143(20):7655-7670. PubMed ID: 33988982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Axl with an high-affinity inhibitory aptamer.
    Cerchia L; Esposito CL; Camorani S; Rienzo A; Stasio L; Insabato L; Affuso A; de Franciscis V
    Mol Ther; 2012 Dec; 20(12):2291-303. PubMed ID: 22910292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.